Week 01/22/2007 through 01/28/2007

Prepared by Capital Hunter analysts:

Venture capital investment managed to rebound, with $416.7 million invested across 36 companies, a 30% increase from last period’s mediocre $325 million. More importantly however venture capitalists spread their investments across many different industries as opposed to concentrating their capital in software, life sciences and digital media companies as has been the case the past few weeks. While software had the strongest showing of any sector, other important industries managed to get their share of the loot as well. Semiconductor investment, which has badly languished the past few weeks, received a big boost, with investments in San Jose-based Achronix Semiconductor, which makes field-programmable gate arrays, and Akustica, a Pittsburgh-based firm that provides system-on-a-chip solutions for the wireless and consumer electronics industries. High-tech electronics investment also did well, with companies such as A123 Systems, a Watertown, Massachusetts based provider of low-cost lithium batteries for laptops, PDAs and other portable consumer electronics, receiving $40 million in Series D funding from a bevy of notable venture firms despite having received $30 million (Series C) early last year from many of those same firms. Network equipment and telecommunications companies also managed to do well, taking in a combined $50 million, close to the total investment those sectors received the past few weeks. Alternative energy investment has lagged the past few months, likely due to the fact that oil has come down from its lofty highs the past year and is making certain sub-sectors of the industry economically unfeasible despite the sizable tax subsidies companies in the sector receive. We do not expect oil to continue to fall indefinitely, so if oil ever begins to rise again you’ll probably see more investment going to the sector. Hopefully we’ll see better investment numbers over the next few weeks, but we are unsure as to what the weeks ahead hold.

The IPO market finally had a bit of an uptick this period, with four companies listing on the NASDAQ, the highest total since late last year. The largest of the bunch is Mereulo Maddox Properties, a developer of commercial and residential properties in densely populated areas in California, which priced at $400 million and is up approximately 6% from its first day of trading Thursday. The most interesting on the bunch however is Oculus Innovative Sciences, and not just because it is from an industry that venture capitalists actually invest in. Oculus, which makes acute wound treatment products, raised close to $60 million since 2003 not from well heeled venture capital firms but from accredited investors brokered by Brookstreet Securities. At least 361 separate accredited investors took part in the companies financing, raising $8 million in Series A funding in 2004 and $47.4 million in Series B funding in 2005, a far cry from the multitude of life science funds and biotech companies that generally participate in large life science deals. While this certainly does not signify a trend, it is something that we will keep an eye on and look into. Well, without further ado, here are the four companies that braved the public market waters:

Aerovironment NASDAQ:AVAV priced at $113.9 million and is a developer of small unmanned aircraft for the Department of Defense.

Oritani Financial MHC NASDAQ:ORIT priced at $150 million and is the holding company of Oritani Financial, a provider of banking services to customers in New Jersey.

Oculus Innovative Sciences NASDAQ:OCLS priced at $105.8 million and is a provider and developer of chronic and acute wound care products.

Mereulo Maddox Properties NASDAQ:MMPI priced at $400 million and is a developer and redeveloper of commercial and residential real estate in California.

Please come visit our web site at CapitalHunter.com. We have made improvements to both the look and functionality of our web site, including business resources, glossary terms, and other helpful information provided free of charge for the budding entrepreneur. For private equity firms, consulting firms, business journals, and individuals looking to do research on venture backed companies, you can still gain complete access to our entire database for $59 a quarter and $199 a year.

CapitalHunter.com was able to verify that $417 million of venture capital was invested in 36 U.S.-based companies during the past week. The average deal size was approximately 11.58 million. The amount of venture capital invested this period increased by 28% compared the last period’s $325 million.

California was the largest recipient of venture capital funding this week. Nineteen California companies raised $238.4 million in new equity financing, which accounted for 58% of the total venture capital invested this reporting period. The largest venture investment in California was placed into Cylene Pharmaceuticals. Cylene Pharmaceuticals raised $44 million in Series C funding and is a developer of small molecules for the treatment of cancer-related diseases.
The software sector raised the most venture capital this reporting period, with thirteen companies raising $108.3 million in venture financing. Software companies accounted for approximately 26% of the venture capital this period. The largest venture investment in the software sector was placed into Veracode. Veracode raised $19.5 million in Series A funding and provides automated software-as-a-service solutions for security applications.
Start-ups raising their second stages of funding represented the largest share of the funding pie, as 33% of all money invested this period went into such companies. The largest Series B funding was placed into Vertiflex. Vertiflex raised $20 million and is an early-stage company developing spinal care products.
The three largest venture deals this period are as follows:
  Company Industry Investment
1 Cylene Pharmaceuticals Biotechnology $44 million
2 A123 Systems Electronics $40 million
3 Achronix Semiconductors $25 million


The following nineteen companies and other unnamed investors funded the above mentioned top three venture capital investments for $109.4 million:
1Alliance Capital
2Battery Ventures
3BioVentures Partners
4Celgene
5Easton Capital
6Entrepia Ventures
7FA Technology Ventures
8GE Commercial Finance
9HBM BioVentures
10Lilly Ventures
11Mitsui & Company
12Motorola
13New Science Ventures
14Novartis BioVenture Fund
15Proctor & Gamble
16Qualcomm
17Research Corporation
18Sanderling Ventures
19Sequoia Capital

A total of 73 equity financings of private and public companies occurred during this reporting period. Each of the 73 equity financings are profiled in a weekly (in this case biweekly) report which include venture financings, private placements, secondary offerings, PIPE’s, and IPO’s.

About CapitalHunter.com

CapitalHunter.com is a web-based financial information company that identifies, preserves and electronically disseminates worldwide data on venture capital and other equity financings. Customers utilize the CapitalHunter.com searchable database to research newly and historic financings and to identify active investors.

Please visit www.capitalhunter.com and get immediate access. New subscribers can request a free investor analysis.
©2003 Capital Hunter, Inc. all rights reserved

To be REMOVED from this free service, CLICK HERE


Features
Venture Capital Activity Highlights
Venture Capital Investments by Region
Venture Capital Investments by Sector
Venture Capital Investments by Round
Top Three Venture Capital Investments
Venture Capitalists Funding the Top Three Deals
Unsubscribe